Glycosidase inhibitors
US11612599B2 · kind B2 · utility
6Cited by
19References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 24, 2017 |
| Grant date | Mar 28, 2023 |
| Priority date | — |
| Expiry date | Apr 5, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I), wherein A, R, W, Q, n and m have the meaning according to the claims, can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.